Lupus (SLE): nyitott vizsgálatok itt: Ausztrália

24 nyitott vizsgálatnak van helyszíne itt: Ausztrália. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07629583
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Kísérleti kezelés · 1. fázis · Genentech, Inc.
Royal Melbourne Hospital, Parkville
Regiszter frissítve: 2026-11-05
NCT07649265
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Kísérleti kezelés · 1. fázis · Otsuka Pharmaceutical Development & Commercialization, Inc.
Q-Pharm Pty Ltd, Brisbane
Regiszter frissítve: 2026-11-05
NCT07332481
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Rheumatology Research Unit Sunshine Coast, Maroochydore · The Alfred Hospital - PARENT, Melbourne · John Hunter Hospital - PARENT, New Lambton Heights
Regiszter frissítve: 2026-11-04
NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Monash Medical Centre Clayton, Clayton
Regiszter frissítve: 2026-11-04
NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
BOX HILL, Box Hill · Footscray Hospital - Western Health, Footscray · Ipswich Hospital, Ipswich
Regiszter frissítve: 2026-11-03
NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Kísérleti kezelés · 1. fázis · Merck Sharp & Dohme LLC
Gold Coast University Hospital (Site 1601), Southport
Regiszter frissítve: 2026-11-02
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Kísérleti kezelés · 1. fázis · AstraZeneca
Birtinya · Clayton
Regiszter frissítve: 2026-10-28
NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 2. fázis · Boehringer Ingelheim
Austin Health, Heidelberg · Fiona Stanley Hospital, Murdoch
Regiszter frissítve: 2026-10-28
NCT07630714
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
Kísérleti kezelés · 2. fázis · AstraZeneca
Nedlands · Parkville · Southport · Westmead
Regiszter frissítve: 2026-10-28
NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Kísérleti kezelés · 3. fázis · AstraZeneca
Melbourne · Mitcham
Regiszter frissítve: 2026-10-28
NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Kísérleti kezelés · 1. fázis · Cullinan Therapeutics Inc.
Royal Melbourne Hospital, Parkville · Osteoporosis Solutions, Victoria Park
Regiszter frissítve: 2026-10-26
NCT07778446
A Study to Test CRT-402 in Refractory Autoimmune Disease
Kísérleti kezelés · 1/2. fázis · Myeloid Therapeutics
Linear Advanced Clinical Trial Centre, Ground Floor, B Block, Queen Elizabeth II Medical Centre, Hospital Avenue, Nedlands
Regiszter frissítve: 2026-10-22
NCT06647069
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Kísérleti kezelés · 1. fázis · Sanofi
Melbourne
Regiszter frissítve: 2026-10-21
NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Maroochydore
Regiszter frissítve: 2026-10-13
NCT07276958
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Kísérleti kezelés · 1. fázis · Eli Lilly and Company
Nucleus Network, Brisbane · Nucleus Network, Melbourne
Regiszter frissítve: 2026-10-08
NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Kísérleti kezelés · 2. fázis · Amgen
Linear Clinical Research Limited, Perth
Regiszter frissítve: 2026-10-05
NCT07038447
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Kísérleti kezelés · 1. fázis · Kite, A Gilead Company
St. Vincent's Hospital, Fitzroy · Concord Repatriation General Hospital, Syndey
Regiszter frissítve: 2026-09-28
NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Kísérleti kezelés · 1/2. fázis · AstraZeneca
Darlinghurst · Melbourne
Regiszter frissítve: 2026-09-10
NCT06917742
A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 1. fázis · Capstan Therapeutics
Veritus Research, Bayswater · Nucleus Network Brisbane, Herston · Linear Clinical Research, Nedlands
Regiszter frissítve: 2026-07-16
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Kísérleti kezelés · 1. fázis · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Brisbane · Camperdown · Clayton
Regiszter frissítve: 2026-07-14
NCT06557265
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Kísérleti kezelés · 1/2. fázis · Nkarta, Inc.
Parkville
Regiszter frissítve: 2026-06-04
NCT06625671
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
Kísérleti kezelés · 1/2. fázis · DualityBio Inc.
Melbourne
Regiszter frissítve: 2026-06-02
NCT07491900
A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 1. fázis · Hinge Bio
Brisbane
Regiszter frissítve: 2026-03-25
NCT03138941
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Kutatás · Monash University
Department of Rheumatology, Flinders Medical Centre, Adelaide · Rheumatology Unit, Royal Adelaide Hospital, Adelaide · School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing & Health Sciences, Clayton · Department of Rheumatology, St Vincent's Hospital (Melbourne), Fitzroy
Regiszter frissítve: 2024-12-12

Minden vizsgálat (Lupus (SLE)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek